Seeking Alpha

Keryx Biopharmaceuticals Inc. (KERX)

()

News & PR
Market Currents

Buzz
Twitter: KERX

Business Intelligence
Transcripts
Events
Key Developments

Instablog posts on KERX

Wednesday's Hot Stocks on Heavy Volume & A Potential Golden Option Trade by Marco Hickey
With the major indices trading mixed Wednesday, there were many stocks which traded higher on BIG volume. The list described below is a large one which is quite unusual for a rather flat trading day. As always, the first thing I do is scan the list for familiar names, such as stocks which have... More »
December 3, 2009 • DIA, SPY, QQQQ
Biotech Baker’s Dozen to Watch at Hematology Meeting by Michael Becker
The 51st American Society of Hematology [ASH] Annual Meeting will take place December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. This is the premier event for the hematology industry, attracting more than 20,000 hematologists and other health-care... More »
November 29, 2009 • AEZS, ALTH, ARIA
Healthcare News Recap for Friday 11/07/09 by M. E. Garza
Below is a list of the healthcare sector companies that made news in the healthcare sector on Friday, November 7, 2009. This list feature is meant to help investors keep tabs on the sector without having to scour through all the press releases.Helix BioMedix, Inc. (OTC:HXBM), a developer of... More »
November 7, 2009 • PPDI, ONCY, LH
Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern by Justin M. Hall
On Friday, Spectrum Pharmaceuticals (SPPI) announced the company sold $50 million worth of common shares at $7.55. As is often the case when a company sells its shares the share price falls.Shares of SPPI closed down -4.39% to $7.18 in Friday trading.As result of this most recent offering... More »
September 18, 2009 • SPPI, ARIA, AGN
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up by Justin M. Hall
As many, who have followed and/or invested in Spectrum Pharmaceuticals (SPPI), know Zevalin® was finally (and thankfully) approved last Friday, September 4 by the FDA for first-line consolidation use in patients with non-Hodgkins lymphoma (NHL). PRELIMINARY FACTSZevalin is the first of... More »
September 11, 2009 • BMY, PFE, OSIP
26 Bullish Breakout Stocks on Big Volume by Marco Hickey
I know I'm a day late as I usually post this on my blog Sunday night, but it's better late than never- right? In this post I have identified an updated list of 26 stocks which have broken out on big (very unusual) volume. As always, I believe the stocks listed in this post are worthy of adding... More »
August 4, 2009 • ONTY, ABAT, CVGI
FDA Calendar Updates: MITI, KERX, GSK, DYAX, ARNA, PGNX by Mike Havrilla
Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of about 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the... More »
June 8, 2009 • MITI, KERX, GSK
Keryx: Another beneficiary of the ASCO-effect by Michael Becker
In my prior article, I highlighted the “ASCO-effect," which relates to the fact that biotechnology companies working in the field of cancer can experience double or triple-digit stock price increases from the end of April through the American Society of Clinical Oncology (ASCO) annual... More »
June 2, 2009 • KERX, AEZS, EXEL
Today's update by dividendmachine
Our long today KERX opened at 1.40 and ran quickly to 1.44 where we grabbed a fast 2.86% profit
June 1, 2009 • KERX
Seth Klarman, Meryl Witmer & David Einhorn 2009 Q1 13F Filings by Davy Bui
This quarter's filings are particularly interesting because they encompass the most recent bear market low which occurred in early March. So without further adieu, here are my thoughts on the filings for Klarman, Witmer and Einhorn. You can view Baupost's portfolio changes in spreadsheet view... More »
May 19, 2009 • CTV, CF, HES

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Keryx Biopharmaceuticals Inc. (KERX)

Instablog posts on KERX

Wednesday's Hot Stocks on Heavy Volume & A Potential Golden Option Trade by Marco Hickey

Biotech Baker’s Dozen to Watch at Hematology Meeting by Michael Becker

Healthcare News Recap for Friday 11/07/09 by M. E. Garza

Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern by Justin M. Hall

Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up by Justin M. Hall

26 Bullish Breakout Stocks on Big Volume by Marco Hickey

FDA Calendar Updates: MITI, KERX, GSK, DYAX, ARNA, PGNX by Mike Havrilla

Keryx: Another beneficiary of the ASCO-effect by Michael Becker

Today's update by dividendmachine

Seth Klarman, Meryl Witmer & David Einhorn 2009 Q1 13F Filings by Davy Bui

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers